Superbrewed Food Launches Shelf-Stable Thryvia Postbiotic
New Castle, Delaware, August 19, 2026 Superbrewed Food, Inc. has announced the commercial launch of Thryvia™, a shelf-stable, protein-derived...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
New Castle, Delaware, August 19, 2026 Superbrewed Food, Inc. has announced the commercial launch of Thryvia™, a shelf-stable, protein-derived...
Scottsdale, Arizona, August 19, 2026 Allure Beauty Concepts has converted its Scottsdale facility into a fully FDA-registered, cGMP-compliant over-the-counter...
New Delhi, India & New York, United States, August 19, 2026 Zeon Lifesciences, an India-based nutraceutical manufacturer, has strengthened...
SPOKANE, Wash., May 7, 2026 LiT Biosciences, LLC announced the launch of LiT Protect, a patent-pending botanical dietary supplement...
IRVINE, Calif., April 08, 2026 iHerb Holdings, Inc., a leading global e-commerce platform for health and wellness products, has...
LISHUI, China, January 14, 2026 — Farmmi, Inc. announced that its U.S. subsidiary, Suppchains Group Inc., has successfully completed...
